COVID-19 vaccine offers lesser, delayed protection against infection in people with cirrhosis
COVID-19 vaccine offers lesser, delayed protection against infection in people with cirrhosis A study shows for the first time that people with cirrhosis who receive mRNA COVID-19 vaccination gain important protection against more serious outcomes like hospitalization and death. At the same time, however, the vaccines offer less protection against SARS-CoV-2 infection and take longer to take effect in this population. Before this research, published July 13 in JAMA Internal Medicine, how much protection the vaccines offered people with cirrhosis was unknown. Clinical trials of the vaccines e...
Source: news-medical.net